Pharmacological characterization and autoradiographic localization of substance P receptors in guinea pig brain
- PMID: 2432587
- DOI: 10.1016/0196-9781(86)90106-3
Pharmacological characterization and autoradiographic localization of substance P receptors in guinea pig brain
Abstract
[3H]Substance P ([3H]SP) was used to characterize substance P (SP) receptor binding sites in guinea pig brain using membrane preparations and in vitro receptor autoradiography. Curvilinear Scatchard analysis shows that [3H]SP binds to a high affinity site (Kd = 0.5 nM) with a Bmax of 16.4 fmol/mg protein and a low affinity site (Kd = 29.6 nM) with a Bmax of 189.1 fmol/mg protein. Monovalent cations generally inhibit [3H]SP binding while divalent cations substantially increased it. The ligand selectivity pattern is generally similar to the one observed in rat brain membrane preparation with SP being more potent than SP fragments and other tachykinins. However, the potency of various nucleotides is different with GMP-PNP greater than GDP greater than GTP. The autoradiographic distribution of [3H]SP binding sites shows that high amounts of sites are present in the hippocampus, striatum, olfactory bulb, central nucleus of the amygdala, certain thalamic nuclei and superior colliculus. The cortex is moderately enriched in [3H]SP binding sites while the substantia nigra contains only very low amounts of sites. Thus, the autoradiographic distribution of SP binding sites is fairly similar in both rat and guinea pig brain.
Similar articles
-
Autoradiographic distribution of brain neurokinin-1/substance P receptors using a highly selective ligand [3H]-[Sar9,Met(O2)11]-substance P.Brain Res. 1990 Oct 29;531(1-2):333-7. doi: 10.1016/0006-8993(90)90796-e. Brain Res. 1990. PMID: 1705154
-
Specific binding of [3H]substance P to the rat submaxillary gland. The effects of ions and guanine nucleotides.J Pharmacol Exp Ther. 1985 Aug;234(2):326-36. J Pharmacol Exp Ther. 1985. PMID: 2410593
-
Specific labeling of rat brain substance P receptor with [3H]physalaemin.J Neurosci. 1985 Aug;5(8):2078-85. doi: 10.1523/JNEUROSCI.05-08-02078.1985. J Neurosci. 1985. PMID: 2991482 Free PMC article.
-
A comparison of the anatomical distribution of substance P and substance P receptors in the rat central nervous system.Peptides. 1984 Nov-Dec;5(6):1097-128. doi: 10.1016/0196-9781(84)90177-3. Peptides. 1984. PMID: 6085163 Review.
-
Comparison of binding assay and biological activity on a NK-1 system with new selective agonists.Neuropeptides. 1989 Nov-Dec;14(4):275-83. doi: 10.1016/0143-4179(89)90057-7. Neuropeptides. 1989. PMID: 2482952 Review.
Cited by
-
Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system.Int J Inflam. 2013;2013:578480. doi: 10.1155/2013/578480. Epub 2013 May 29. Int J Inflam. 2013. PMID: 23819099 Free PMC article.
-
Investigation into species variants in tachykinin NK1 receptors by use of the non-peptide antagonist, CP-96,345.Br J Pharmacol. 1991 Oct;104(2):292-3. doi: 10.1111/j.1476-5381.1991.tb12423.x. Br J Pharmacol. 1991. PMID: 1665729 Free PMC article.
-
The role of substance p in ischaemic brain injury.Brain Sci. 2013 Jan 30;3(1):123-42. doi: 10.3390/brainsci3010123. Brain Sci. 2013. PMID: 24961310 Free PMC article.
-
The pharmacology of GR203040, a novel, potent and selective non-peptide tachykinin NK1 receptor antagonist.Br J Pharmacol. 1995 Dec;116(8):3149-57. doi: 10.1111/j.1476-5381.1995.tb15117.x. Br J Pharmacol. 1995. PMID: 8719789 Free PMC article.
-
Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.Br J Pharmacol. 1995 Nov;116(5):2496-502. doi: 10.1111/j.1476-5381.1995.tb15101.x. Br J Pharmacol. 1995. PMID: 8581290 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous